Showing 17 of 17 results

Magdalena Bastías, Iván Brstilo, Cecilia González
En marzo 2020, la Organización Mundial de la Salud (OMS) hizo un llamado a mantener la vacunación programática siempre que se pudieran garantizar condiciones seguras frente a la circulación...
De la Hoz Restrepo et al.
Three highly effective vaccines are available to prevent human papillomavirus (HPV) infection, and they have been introduced in many countries around the world. This article describes advances and...
Ángela MaríaRuiz-Sternberg
Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine....
Cristina Pedreira et al.
The synchronized introduction of the inactivated polio vaccine (IPV) and the switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV) has constituted an effort without...
Despite its promise, however, the digital health landscape today is highly fragmented. The result is a myriad of digital health projects and applications that rarely reach scale and if they were to...
Jorge Alberto Gomez et al.
Background In Chile, significant reductions in cervical cancer incidence and mortality have been observed due to implementation of a well-organized screening program. However, it has been suggested...
Martí SG et al.
BACKGROUND: A recently developed 10-valent pneumococcal non-typeable H influenzae protein D-conjugate vaccine (PHiD-CV) is expected to afford protection against more than two thirds of isolates...
Zhifang Wang et al.
The reported coverage of the measles–rubella (MR) or measles–mumps–rubella (MMR) vaccine is greater than 99.0% in Zhejiang province. However, the incidence of measles, mumps, and rubella...
Philip S. Watsona & David P.J. Turnerb
Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults. Vaccines have been successfully introduced to help protect against...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
Sachiko Ozawa et al.
Triangulation of results from two methods captured a richer story behind vaccine adoption decisions for hepatitis A. The discrepancy between policymakers’ beliefs and existing data suggest a...
Miguel O\'Ryan et al.
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus...
Rifat Atun et al.
Starting in the late 1980s, many Latin American countries began social sector reforms to alleviate poverty, reduce socioeconomic inequalities, improve health outcomes, and provide financial risk...